Our chemistry starts where conventional design and synthesis stop, adding a new dimension to the RNA development workflow.
Source-reported As recorded 2026-10-25
Browser storage is unavailable. Keep this page open and export your collection before leaving.
Biotech pharma
Amptiv Biosciences
Overview
Building the first programmable chemical control layer for mRNA therapeutics.
Company description As recorded 2026-11-01
Product & workflow
Customers & use cases
We’re building a programmable control layer to help therapeutic developers match mRNA performance to the demands of each medicine.
Source-reported As recorded 2026-10-25
News & product activity
Cohort membership
Antler 20242024
Original evidence ↗Sources & observations
Profile depthverified profile
Website observationwebsite reachable
Last website check2026-11-11
Location · source statedUS
Pricing evidenceNo pricing page confirmed
Maturity: Not assessed · 2 of 6 areas documented
Source-based assessment · automated evidence rules
The retained text does not establish product availability or customer use.
Maturity is an evidence-based assessment, not a success rating. It may understate the current stage where evidence is limited. Coverage records documented areas, not a complete or independently audited company history.
- Product overviewSource description Checked 2026-11-11
- Product visualsNot documented
- Founders & originsNot documented
- Business model & pricingNot documented
- Funding & ownershipNot documented
- Dated milestonesDated source activity: 2024 (year only)
independent websitesource corroborationreachable websitedescriptive evidenceclassified market and model
Similar businesses
Anthrogen is engineering post-modality biology. Today's modalities reflect historical contingencies in biological progress, not fundamental categories. We develop the AI systems that design modular biological machines and the…
Founders · Product
- Founded
- 2024
- Team
- 15 people
Same product type · Infrastructure
Anto is building a foundation model for microbial communities, making the gut microbiome computable for the first time. We predict drug toxicity and efficacy across diverse populations and fix drugs so they work for everyone — solving…
Founders · Product
- Founded
- 2025
- Team
- 4 people
Same product type · Infrastructure
BioStack is building the data engine for healthcare and drug discovery AI. The bottleneck is not models. It is access to high-quality biological data. Clinical and experimental data is fragmented, unstructured, and locked inside…
Founders · Product
- Founded
- 2025
- Team
- 9 people
Same product type · Infrastructure
Transform scattered lab data into structured insights. Labric automatically captures instrument data, enables AI-powered analysis, and saves research teams hundreds of hours.
Founders · Product · How it works
- Founded
- 2025
- Team
- 6 people
Same product type · Infrastructure
What if we made as many cancer drugs next year as we have in the last decade?
Founders · Product
- Founded
- 2025
- Team
- 4 people
Same product type · Infrastructure
Spatial proteomics from H&E and multimodal patient data imputation. Lattice predicts spatially resolved protein-marker maps from routine H&E slides as virtual multiplex immunofluorescence (mIF) channels, transforming incomplete patient…
Founders · Product · How it works
- Founded
- 2025
- Team
- 2 people
Same product type · Infrastructure